Immunocore Holdings plc (IMCR) Financials

IMCR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.1 billion 678.4 million
Dec. 31, 2025 1.1 billion 686.2 million
Sept. 30, 2025 1.1 billion 705.9 million
June 30, 2025 1.1 billion 693.9 million

IMCR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -15.5 million 6.3 million
Dec. 31, 2025 -35.5 million 8.3 million
Sept. 30, 2025 -5.2 million 9.8 million
June 30, 2025 25.6 million 10.0 million

IMCR Net Income

No data available :(

IMCR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 844.9 million 40.0 million -
Dec. 31, 2025 864.2 million 41.6 million 43.6 million
Sept. 30, 2025 892.4 million 41.4 million 43.3 million
June 30, 2025 882.8 million 392.1 million 44.4 million

IMCR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 52.9 million
Dec. 31, 2025 50.3 million
Sept. 30, 2025 50.4 million
June 30, 2025 50.3 million

IMCR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 1.8 million 61.1 million 37.9 million -
Dec. 31, 2025 2.9 million 58.4 million 31.0 million -
Sept. 30, 2025 748000 70.6 million 39.8 million -
June 30, 2025 414000 69.0 million 42.8 million -

IMCR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 106.7 million 434000
Dec. 31, 2025 77.4 million 2.6 million
Sept. 30, 2025 103.7 million 513000
June 30, 2025 98.0 million 1.0 million

IMCR Revenue by Segment
Graph available only for paid members. Upgrade to see it.

IMCR

Price: $28.96

52 week price:
27.56
40.72

Earnings Per Share: -0.56 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United Kingdom

Volume: 522338

Market Capitalization: 1.4 billion

Links: